Lyons, France

Philippe Guèdat


Average Co-Inventor Count = 5.5

ph-index = 2

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 2004-2010

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Philippe Guèdat: Innovator in Lipid Management

Introduction: Philippe Guèdat, a dedicated inventor based in Lyons, France, has made significant strides in the field of pharmaceutical innovations. With a focus on addressing metabolic disorders, Guèdat's contributions to the medical community have not gone unnoticed. As a member of Merck Patent GmbH, he has been integral in the development of new therapeutic solutions.

Latest Patents: Philippe Guèdat holds a patent for thiazolylpiperidine derivatives as MTP (Microsomal Triglyceride Transfer Protein) inhibitors. This groundbreaking invention consists of compounds formulated to treat hypertriglyceridaemia, hypercholesterolaemia, and dyslipidaemia. The compounds of the general formula (I) present a promising approach to managing lipid levels in patients, potentially alleviating various cardiovascular risks associated with these conditions.

Career Highlights: Throughout his career, Guèdat has proven himself to be a valuable asset at Merck Patent GmbH. His extensive work on lipid management technologies showcases his deep understanding of medicinal chemistry and his commitment to advancing healthcare solutions. By focusing on innovative drug design, he continues to address critical health issues faced by many individuals worldwide.

Collaborations: Philippe Guèdat has had the opportunity to work alongside notable colleagues such as Francois Collonges and Hervé Dumas. Their collaborative efforts have led to enhanced research outcomes, contributing to the development of effective treatments. Working together within Merck Patent GmbH, they strive to push the boundaries of pharmaceutical research and improve patient outcomes.

Conclusion: Philippe Guèdat exemplifies the innovative spirit within the pharmaceutical industry. His patent on thiazolylpiperidine derivatives plays a crucial role in managing lipid disorders, making a positive impact in the field of medicine. With a strong foundation of collaboration and research, Guèdat and his team continue to pave the way for future advancements in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…